Use of N terminal Pro Brain Natriuretic Peptide (NTproBNP) for assessment of risk of contrast induced nephropathy (CIN) in patients undergoing elective percutaneous coronary intervention (PCI)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.